Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.9469
+0.0119 (1.27%)
Nov 28, 2025, 1:00 PM EST - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $34.27 million as of November 28, 2025. Its market cap has increased by 1.68% in one year.
Market Cap
34.27M
Enterprise Value
30.40M
1-Year Change
1.68%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $34.27M, a decrease of -63.85%. That is a compound annual growth rate of -14.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 34.30M | -33.78% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |